Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

Spire slashing 400 hospital jobs to increase efficiency and flexibility

Spire, the UK’s largest for-profit hospital group, plans to hand out redundancy packages to about 400 of its ~14,000 employees (~2.5%) as part of an initiative to create operational efficiencies and have a higher proportion of bank (i.e. part-time) workers. The jobs being cut include clinical as well as admin staff, but the group says there will be no reduction in patient-facing clinical hours.

In-receivorship Healthscope receives 10 non-binding offers

Healthscope, Australia’s second largest private hospital group, has received 10 non-binding indicative takeover offers, according to its CEO. This comes after the group’s US private equity owner Brookfield handed over control of the business to creditors after failing to resolve its financial issues.

Keys Group buys ADHD 360

Keys Group, a UK provider of child and adult education and care services, has acquired ADHD 360, one of the UK’s largest private providers of services for people with ADHD.

PHP attempts to outbid KKR for Assura

Primary Healthcare Properties (PHP), a listed UK REIT focused on the primary care sector, has upped its bid for Assura, its main competitor as the only other REIT with a significant portfolio of UK GP practices. US PE firms KKR and Stonepeak have meanwhile reiterated their joint offer for Assura, saying PHP’s would be more risky. Assura has delayed its planned shareholder vote on the KKR/Stonepeak offer to properly consider the new PHP offer.

Health crisis in Colombia sees hospital unit closures and medication shortages

Earlier this month reports showed Colombia’s already-struggling health system seeing units in hospitals in capital Bogotá being forced to close down to be able to continue other types of care services. In recent months patients have also been denied access to medications and health services, with the financial crisis facing the healthcare sector in the country still unfolding. 

23andMe to be bought by US biotech company Regeneron

US-based biotech company Regeneron Pharmaceuticals intends to buy the assets of genetics-led consumer healthcare and biotech company 23andMe in a bankruptcy auction, both companies announced on Monday.

Find Us